EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

[¹⁸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution

Yi Wang, Lijuan Feng, Limeng He, Nan Liu, Hao Wang iD

PLOS One · 14.05.2026 · 21 (5) · e0349397

DOI: 10.1371/journal.pone.0349397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 14.05.2026. Verfasst von Yi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Zigong Fourth People's Hospital, Zigong, Sichuan, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Prostatectomy, Niacinamide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To define the diagnostic yield and anatomical distribution of [¹⁸F]prostate-specific membrane antigen (PSMA)-1007 positron emission tomography/computed tomography (PET/CT) in post-radical-prostatectomy biochemical recurrence (BCR) and to establish prostate-specific antigen (PSA)-stratified performance benchmarks, independent predictors of PET positivity, and clinical utility for PSMA-guided metastasis-directed therapy.

Methods

A single-centre retrospective cohort of 245 consecutive BCR patients (PSA ≥ 0.2 ng/mL) who underwent uniform [¹⁸F]PSMA-1007 PET/CT (90 ± 10 min post-injection; molar activity > 30 GBq µmol⁻¹) between June 2022 and November 2025 was analysed. Detection rates were correlated with PSA strata, and independent predictors of PET positivity were identified via multivariable logistic regression. Lesion location was verified by histology, targeted therapy response, or unequivocal imaging follow-up. Inter-observer agreement for image interpretation was quantified using Cohen’s kappa, Results At median PSA 0.9 ng/mL (interquartile range 0.5–2.1), 184/245 patients (75.1%, 95% CI: 69.3–80.3%) exhibited ≥ 1 [¹⁸F]PSMA-1007-avid lesion. Detection rates increased with PSA: 56.5% (0.2–0.5 ng/mL) to 90.5% (≥ 1.5 ng/mL). Independent predictors of PET positivity were serum PSA (OR = 2.87), ISUP grade (OR = 1.63), and PSA doubling time (OR = 0.72) (all P < 0.01). In 132 verified cases, a “pelvic-first” pattern was observed: isolated prostatic fossa (34.8%), isolated nodal (38.6%), isolated osseous (20.4%), and multi-region disease (6.1%). Median SUVmax was comparable across lesion types (≈ 17.5; P = 0.63), with excellent inter-observer agreement (Cohen’s κ = 0.86 for positivity, 0.82 for localization; both P < 0.001). Conclusion [¹⁸F]PSMA-1007 PET/CT delivers high, PSA-dependent detection efficiency even at PSA < 0.5 ng/mL, with excellent inter-observer reliability. Serum PSA, ISUP grade, and PSA doubling time independently predict PET positivity, and the modality accurately maps predominantly pelvic, oligometastatic recurrences suitable for focal salvage therapy. These data support its utility as a first-line imaging tool for post-prostatectomy BCR staging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyProstatectomyNiacinamideNeoplasm Recurrence, LocalOligopeptidesHumansMaleRetrospective StudiesMiddle AgedAgedProstate-Specific AntigenFluorine Radioisotopes

Substanzen

NiacinamidePSMA-1007OligopeptidesProstate-Specific AntigenFluorine Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Zigong Fourth People's Hospital, Zigong, Sichuan, China.
  • Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

ORCID-Profile: Hao Wang

Zitieren

APA

Wang, Y., Feng, L., He, L., Liu, N., & Wang, H. (2026). [¹⁸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution. PLOS One, 21(5), e0349397. https://doi.org/10.1371/journal.pone.0349397

Vancouver

Wang Y, Feng L, He L, Liu N, Wang H. [¹⁸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution. PLOS One. 2026;21(5):e0349397. doi:10.1371/journal.pone.0349397

BibTeX
@article{Wang2026,
  author = {Wang, Yi and Feng, Lijuan and He, Limeng and Liu, Nan and Wang, Hao},
  title = {[¹⁸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {5},
  pages = {e0349397},
  doi = {10.1371/journal.pone.0349397}
}
Kostenlos starten →